Mode
Text Size
Log in / Sign up
Phase 1 Completed N=254 Randomized Single-blind Health Services Research

Home Safety Clinical Trial for Alzheimer's Disease

Source: ClinicalTrials.gov NCT00459355 ↗
Enrolled (actual)
254
Serious AEs
0.8%
Results posted
Sep 2014
Primary outcomePrimary: Caregiver Strain — 5.95; 6.96 units on a scale — p=<0.0001

Summary

The purpose of this study was to test the effectiveness of a new multimodal educational intervention to improve home safety for persons with dementia of the Alzheimer's type and their home caregivers.

Outcome Measures

OutcomeResultp-value
PRIMARY
Caregiver Strain
5.95; 6.96 <0.0001 sig
PRIMARY
Caregiver Self-efficacy
1350.30; 1305.65 .002 sig
SECONDARY
Care Recipient Risky Behaviors and Accidents
33.95; 37.44 <.0001 sig

Eligibility Criteria

Inclusion Criteria

  • Subjects are dyads of primary caregivers and persons with a progressive DAT who live in the community, are willing to have home visits for home safety education, and who read and speak English.
  • Inclusion criteria for care recipients are: diagnosis of DAT, score of 24 or less on the Mini-Mental State Exam (MMSE), is expected to continue living in the community for the next 6 months, and has the ability to ambulate without help from the caregiver.
  • Inclusion criteria for the primary informal caregiver are: lives in the home with the care-recipient, provides a minimum of 4 hours of care-giving or supervision per day, and has no known cognitive impairment as judged by the primary care provider who refers the subject dyad for study recruitment.

Exclusion Criteria

  • Care-recipient MMSE score of 25 or greater.
  • A previous home safety visit.
  • Admission to a long-term care facility. - Persons with DAT who are living alone will be excluded because their safety issues are more complex and there is no primary informal caregiver who can make consistent observations about risky behaviors and accidents.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00459355). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search